In this context, molecular docking studies were conducted to investigate the interactions between fatty acid amides (FAAs) and cannabinoid receptors CB1 and CB2, which are relevant targets in the context of breast cancer due to their role in modulating tumor-related processes and interacting with the endocannabinoid system. The gene discussed is CNR1; the disease is breast cancer.